Cargando…
Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226609/ https://www.ncbi.nlm.nih.gov/pubmed/27246983 http://dx.doi.org/10.18632/oncotarget.9641 |
_version_ | 1782493677839450112 |
---|---|
author | Lu, Cheng-Lin Cao, Ya-Juan Cheng, Hao Pan, Yi-Ming Bao, Shan-Hua Xie, Min |
author_facet | Lu, Cheng-Lin Cao, Ya-Juan Cheng, Hao Pan, Yi-Ming Bao, Shan-Hua Xie, Min |
author_sort | Lu, Cheng-Lin |
collection | PubMed |
description | There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect the outcomes of selective devascularization procedures. Elucidating these features may guide future treatment of esophageal varices in patients with portal hypertension. We retrospectively analyzed medical records of 455 patients who underwent selective devascularization procedures in our center. Patients were subject to splenectomy, selective devascularization with or without esophageal transection. The mode of surgery recurred in comparable rates in both the group with major complications postoperatively (high-risk group which consisted of 63 patients) or the group without major postoperative complications (low-risk group, 392). Risk factors that negatively influenced outcomes of surgery include severe symptoms (89% in high risk group and 71% in low risk group), large volume of blood loss in the hemorrhage before surgery (81% in high risk group and 16% in low risk group), sever liver cirrhosis (83% in high risk group and 67% in low risk group), previous endotherapy, prolonged prothrombin time, and poor liver function. Selective devascularization is a feasible option to treat variceal hemorrhage in patients with portal hypertension. |
format | Online Article Text |
id | pubmed-5226609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-52266092017-01-18 Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension Lu, Cheng-Lin Cao, Ya-Juan Cheng, Hao Pan, Yi-Ming Bao, Shan-Hua Xie, Min Oncotarget Clinical Research Paper There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect the outcomes of selective devascularization procedures. Elucidating these features may guide future treatment of esophageal varices in patients with portal hypertension. We retrospectively analyzed medical records of 455 patients who underwent selective devascularization procedures in our center. Patients were subject to splenectomy, selective devascularization with or without esophageal transection. The mode of surgery recurred in comparable rates in both the group with major complications postoperatively (high-risk group which consisted of 63 patients) or the group without major postoperative complications (low-risk group, 392). Risk factors that negatively influenced outcomes of surgery include severe symptoms (89% in high risk group and 71% in low risk group), large volume of blood loss in the hemorrhage before surgery (81% in high risk group and 16% in low risk group), sever liver cirrhosis (83% in high risk group and 67% in low risk group), previous endotherapy, prolonged prothrombin time, and poor liver function. Selective devascularization is a feasible option to treat variceal hemorrhage in patients with portal hypertension. Impact Journals LLC 2016-05-26 /pmc/articles/PMC5226609/ /pubmed/27246983 http://dx.doi.org/10.18632/oncotarget.9641 Text en Copyright: © 2016 Lu et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Research Paper Lu, Cheng-Lin Cao, Ya-Juan Cheng, Hao Pan, Yi-Ming Bao, Shan-Hua Xie, Min Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title | Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title_full | Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title_fullStr | Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title_full_unstemmed | Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title_short | Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
title_sort | clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension |
topic | Clinical Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226609/ https://www.ncbi.nlm.nih.gov/pubmed/27246983 http://dx.doi.org/10.18632/oncotarget.9641 |
work_keys_str_mv | AT luchenglin clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension AT caoyajuan clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension AT chenghao clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension AT panyiming clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension AT baoshanhua clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension AT xiemin clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension |